13:30 - Welcome

Dr Shirley Bowles, ACB NW Committee Chair

13:40 - Performance of the Quantitative High-throughput Roche Assay for SARS-CoV-2- spike Antibodies and a 6-assay Comparison

Christopher Hughes, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust

13:55 - Cardiovascular and LDL Outcome in a Cohort of 39 Patients on PCSK9 Inhibitors

Dr John Bassett, Royal Liverpool University Hospital

14:10 - Development and Validation of a LC-Q-TOF-MS Assay for Qualitative Screening of Anti-Hypertensive Drugs in Urine

Laura Walker, Alder Hey Children’s Hospital

14:25 -  Advancing Research with the SARS-CoV-2 LC-MS Kit (RUO) Industrial presentation – Waters Corporation

Dominic Foley, Principal Scientist

14:55 - Tea/Coffee break

15:15 - Clinical Utility of Free Androgen Index (FAI) in the Assessment of PCOS

Saliha Haji, Royal Liverpool University Hospital

15:30 - Vitamin B12 Deficiency: Leave Your Assumption at the Door

Daniella Clegg, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust

15:45 - A Novel Assay Architecture Exhibits Increased Analytical Sensitivity in Lateral Flow Antibody Immunoassays; Observations from Dengue Virus Serology

Ian Laing, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust

16:00 - AGM

16:40 - Ian Ward judging and awards presentation

16:50 - Close